Literature DB >> 21194520

Mitochondrial proteases and cancer.

Anne-Laure Bulteau1, Aurelien Bayot.   

Abstract

Mitochondria are a major source of intracellular reactive oxygen species, the production of which increases with cancer. The deleterious effects of reactive oxygen species may be responsible for the impairment of mitochondrial function observed during various pathophysiological states associated with oxidative stress and cancer. These organelles are also targets of oxidative damage (oxidation of mitochondrial DNA, lipids, protein). An important factor for protein maintenance in the presence of oxidative stress is enzymatic reversal of oxidative modifications and/or protein degradation. Failure of these processes is likely a critical component of the cancer process. Mitochondrial proteases degrade misfolded and non-assemble polypeptides, thus performing quality control surveillance in the organelle. Mitochondrial proteases may be directly involved in cancer development as recently shown for HtrA2/Omi or may regulate crucial mitochondrial molecule such as cytochrome c oxidase 4 a subunit of the cytochrome c oxidase complex degraded by the Lon protease. Thus, the role of mitochondrial proteases is further addressed in the context of oxidative stress and cancer.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194520     DOI: 10.1016/j.bbabio.2010.12.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  New roles for mitochondrial proteases in health, ageing and disease.

Authors:  Pedro M Quirós; Thomas Langer; Carlos López-Otín
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05-13       Impact factor: 94.444

2.  Adaptor-mediated Lon proteolysis restricts Bacillus subtilis hyperflagellation.

Authors:  Sampriti Mukherjee; Anna C Bree; Jing Liu; Joyce E Patrick; Peter Chien; Daniel B Kearns
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-23       Impact factor: 11.205

Review 3.  Signaling the mitochondrial unfolded protein response.

Authors:  Mark W Pellegrino; Amrita M Nargund; Cole M Haynes
Journal:  Biochim Biophys Acta       Date:  2012-03-14

4.  Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress.

Authors:  Miriam Polo; Fernando Alegre; Angela B Moragrega; Lara Gibellini; Alberto Marti-Rodrigo; Ana Blas-Garcia; Juan V Esplugues; Nadezda Apostolova
Journal:  Br J Pharmacol       Date:  2017-11-07       Impact factor: 8.739

5.  Autophagy accounts for approximately one-third of mitochondrial protein turnover and is protein selective.

Authors:  Evelyn S Vincow; Ruth E Thomas; Gennifer E Merrihew; Nicholas J Shulman; Theo K Bammler; James W MacDonald; Michael J MacCoss; Leo J Pallanck
Journal:  Autophagy       Date:  2019-03-21       Impact factor: 16.016

Review 6.  Mitochondrial AAA proteases: A stairway to degradation.

Authors:  Tyler E Steele; Steven E Glynn
Journal:  Mitochondrion       Date:  2019-08-01       Impact factor: 4.160

Review 7.  The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?

Authors:  Salvatore Chirumbolo; Geir Bjørklund
Journal:  Int J Clin Oncol       Date:  2016-12-09       Impact factor: 3.402

Review 8.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

9.  StAR enhances transcription of genes encoding the mitochondrial proteases involved in its own degradation.

Authors:  Assaf Bahat; Shira Perlberg; Naomi Melamed-Book; Ines Lauria; Thomas Langer; Joseph Orly
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 10.  Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders.

Authors:  Daniela A Bota; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2016-07-05       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.